ea0056p1040 | Thyroid (non-cancer) | ECE2018
Pietzner Maik
, Homuth Georg
, Kohrle Josef
, Budde Kathrin
, Kastenmuller Gabi
, Brabant Georg
, Volzke Henry
, Artati Anna
, Adamski Jerzy
, Volker Uwe
, Nauck Matthias
, Friedrich Nele
Background: Numerous animal models have shown impressive beneficial metabolic effects of the putative thyroid hormone (TH)-derivative 3,5-diiodothyronine (3,5-T2), including the prevention of insulin resistance or the reversal of hepatic steatosis, in the absence of thyrotoxic side effects. In contrast, the endogenous fate of 3,5-T2 in humans is still unclear. Comprehensive molecular profiling holds promise to gain deeper insights in metabolic alterations associated with serum...